Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
ASH 2014
ASH 2014 – CLL
ASH 2014 - CLL
Interim Analysis of Phase 2 ICLL01: Ofatumumab and High-Dose Methylprednisolone in Patients at Highest Risk for Relapsed/Refractory CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
ONO-4059: A New Oral, Selective BTK Inhibitor for Patients with High-Risk CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Results from the CLL11 Study: Salvage Therapy with Obinutuzumab plus Chlorambucil in Patients with CLL and Comorbidities
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Dose De-Escalation in Fit, Older Patients with CLL: Balancing Efficacy, Safety, and Tolerability
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Update from the RESONATE Trial: Ibrutinib versus Ofatumumab in Relapsed/Refractory CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
The Benefit of Adding Rituximab to Ibrutinib in Relapsed/Refractory CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Interim Analysis of the PROLONG Study: Ofatumumab Maintenance Therapy in Patients with Relapsed CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Ibrutinib Salvage in Relapsed CLL After Allogeneic Transplantation
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Final Results from the CLL20 Study: Alemtuzumab plus Dexamethasone in Very High–Risk Patients with CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Ibrutinib-Based Regimens for Patients with Relapsed/Refractory CLL: Impact of Complex Karyotype
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma